Bioluminescent Multi-Characteristic Opsin for monitoring visual cortical activity upon optical stimulation

Subrata Batabyal, Sivakumar Gajjeraman, Takeharu Nagai, Weldon Wright, Samarendra MohantybioRxiv 2018 · DOI

TL;DR

This paper introduces bMCO-11, a novel bioluminescent protein that allows for non-invasive, excitation-free monitoring of neural activity in the visual cortex. By combining light-activated opsin and a calcium-sensitive bioluminescent reporter, bMCO-11 enables both stimulation and recording of neural signals, offering a promising tool for studying visual system function and dysfunction.

What Problem Does This Paper Address?

Monitoring neural activity non-invasively is crucial for diagnosing neurological conditions, assessing treatment efficacy, and developing therapeutic interventions. In the context of vision loss due to retinal degeneration, optic nerve damage, or eye injury, understanding how visual cortical activity changes during disease progression and potential restoration is vital. Current methods for neural activity detection, such as electroencephalography (EEG) and electrocorticography (ECoG), have limitations in spatial resolution and invasiveness. Optogenetic tools, while powerful for controlling neural activity, often rely on external light sources that can cause phototoxicity and interfere with measurements, especially in the retina where photoreceptors are also sensitive to light. Furthermore, distinguishing between light-induced neural activity and the stimulation light itself can be challenging. This paper aims to address these limitations by developing a system that allows for both optical stimulation and bioluminescent recording of neural activity without the need for external excitation light.

Methods

The core innovation is the development of a bioluminescent multi-characteristic opsin (bMCO-11). This chimeric protein is a fusion of two key components:

  • A highly photosensitive, ambient light-activatable opsin domain (MCO-11): This part of the protein is designed to be activated by light.
  • A Ca²⁺-sensitive bioluminescence reporter (GeNL-Ca²⁺): This component emits light when intracellular calcium levels rise, which is a common indicator of neural activity.

The researchers synthesized this bMCO-11 construct and expressed it in HEK293 cells and in the visual cortex of mice. They employed several techniques:

  • Molecular Cloning and Plasmid Design: Standard molecular biology techniques were used to construct the bMCO-11 gene and insert it into expression plasmids.
  • Cell Culture and Transfection: HEK293 cells were cultured and transfected with the bMCO-11 plasmid to demonstrate cellular expression and functionality.
  • Confocal Microscopy: Used to visualize the expression of bMCO-11 in cells and in the visual cortex.
  • Patch-Clamp Electrophysiology: Employed to record electrical activity (inward currents) in individual cells upon stimulation, demonstrating the functional output of bMCO-11.
  • Optical Stimulation: Localized and wide-area optical stimulation using lasers and Xenon lamps was used to activate the opsin domain.
  • Bioluminescence Imaging: Time-lapse imaging of bioluminescence was performed to monitor Ca²⁺ influx and thus neural activity. This was done without external excitation light, relying solely on the light emitted by the GeNL reporter.
  • In Vivo Imaging: In live mice, an optical window was surgically implanted over the visual cortex to allow for bioluminescence imaging of cortical activity.
  • SD-OCT Imaging: Spectral Domain Optical Coherence Tomography was used to assess retinal structure, particularly in the context of retinal degeneration.

The key novelty lies in the fusion of the opsin and bioluminescence reporter, enabling a self-contained system for light-activated neural stimulation and subsequent bioluminescent readout of activity, and the demonstration of excitation-free monitoring.

Datasets

Not discussed in the paper. The study primarily uses in vitro cell cultures and in vivo animal models (wild-type and rd1 mice).

Key Insights and Ideas

  • Excitation-Free Neural Monitoring: The most significant insight is the successful demonstration of monitoring neural activity using bioluminescence without requiring an external excitation light source. This bypasses the phototoxicity and signal interference issues associated with fluorescence-based methods.
  • Self-Amplifying Signal: The paper suggests that the bioluminescence generated by the GeNL reporter can cyclically activate the opsin domain, leading to a sustained influx of ions (like Ca²⁺) and thus a prolonged bioluminescent signal. This "cyclic activation" mechanism amplifies the signal and allows for longer observation periods.
  • Simultaneous Read and Write Capability: bMCO-11 integrates both "read" (monitoring activity via bioluminescence) and "write" (stimulating activity via light activation of the opsin) functions into a single genetic construct. This opens doors for closed-loop neural control and monitoring systems.
  • Potential for Vision Restoration Research: The ability to monitor visual cortical activity in both healthy and degenerated retinas (using rd1 mice) without external light is crucial for studying the effects of vision loss and the efficacy of potential restoration strategies.

Key Results

  • Stable Expression: bMCO-11 was successfully expressed in HEK293 cells and in the visual cortex of mice.
  • Single-Cell Activation: Localized optical stimulation of bMCO-11 expressing cells in culture led to a significant increase in bioluminescence, indicating Ca²⁺ influx and neural activity.
  • Long-Lasting Bioluminescence: Electrophysiological recordings showed sustained inward currents (>10 sec) in bMCO-11 transfected cells upon optical stimulation, attributed to the bioluminescence-driven cyclic activation. The minimum light intensity required for activation was found to be 37 μW/mm².
  • Wide-Area Synchronized Activity: Wide-area optical stimulation of bMCO-11 expressing cells in culture resulted in synchronized bioluminescence signals across over 90% of the cells.
  • In Vivo Visual Cortex Activity: In wild-type mice with bMCO-11 transfected visual cortex, white light visual stimulation evoked a long-lasting rise in bioluminescence signals, demonstrating visually evoked cortical activity.
  • Retinal Degeneration Impact: In rd1 mice with degenerated retinas, visual stimulation did not elicit a significant bioluminescence response in the visual cortex, unlike in wild-type mice, highlighting the dependence of visually evoked cortical activity on retinal input.

Limitations and Future Work

  • Substrate Instability: The paper notes that the decay in signal intensity during repeated stimulation in cell cultures is attributed to the known instability of the substrate (coelenterazine-h).
  • Temporal Resolution: While the GeNL domain has sub-second kinetics, the overall temporal resolution of the bioluminescence signal might be limited by the diffusion of ions and the cyclic activation process.
  • Clinical Translation: The current work is preclinical. Future work will focus on demonstrating a clinically viable optical stimulation device that can reliably provide stimulation input to the visual cortex and simultaneous recording of cortical activity.
  • Inhibitory Opsin Integration: The authors suggest integrating an inhibitory opsin with the bioluminescence reporter for bidirectional control of neural activity, which could be applied to conditions like pain modulation.
  • Scalability and Modularity: Further development aims to create a modular and scalable interface system capable of modulating and monitoring large-scale neural activity across different brain regions and sensory systems.

Summary updated

Abstract

ABSTRACT Non-invasive detection of neural activity is important for the diagnosis of neurological diseases, evaluation of therapeutic outcomes, and collection of real-time feedback for stimulation based therapeutic approaches. In the case of vision loss, due to retinal degeneration, optic neuropathy, or enucleation of the eye, there is a need to map changes in visual cortical activity during disease progression and subsequent vision restoration by retinal, optic nerve or cortical stimulation. Existing technologies allow interrogation of neuronal circuits by both read and write activity, albeit with inherent limitations. Here, we present the development of bioluminescent multi-characteristic opsin (bMCO-11), which is comprised of a highly photosensitive ambient light-activatable domain and a Ca 2+ -sensitive bioluminescence reporter. The high quantum efficiency of bMCO-11 enables light activation and recording of cellular activity upon local as well as wide area optical stimulation. Furthermore, persistent Ca 2+ influx was achieved by bioluminescence based cyclic activation of the opsin-domain of bMCO-11 by transporting the ions only into bMCO expressing cells. This allowed us to continuously monitor visual cortical activity in wild type and retinal degenerated mice, without requiring any additional external excitation source.
BibTeX
@misc{batabyal2018bioluminescent,
  author = {Subrata Batabyal and Sivakumar Gajjeraman and Takeharu Nagai and Weldon Wright and Samarendra Mohanty},
  title = {{Bioluminescent Multi-Characteristic Opsin for monitoring visual cortical activity upon optical stimulation}},
  year = {2018},
  doi = {10.1101/509323},
  howpublished = {bioRxiv},
}

Loading related content...

Figure